English

Brain Scientific Inc.

EDGAR

Annual report (10-K) · filed 2023-03-31

36 filing records in this dataset, filed from 2016-02-02 to 2023-03-31. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.08 thousand USD

2022 Q4 · USD

Exact inputs and evidence

Revenue: 214564 USD Source
Revenue: 209484 USD Source

Operating margin

-29,590.79%

2022 Q4 · %

Exact inputs and evidence

Operating Income: -9608407 USD Source
Operating Income: -8105195 USD Source
Revenue: 214564 USD Source
Revenue: 209484 USD Source

Operating cash flow

-1.24 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -5935070 USD Source
Operating Cash Flow: -4691693 USD Source

Free cash flow

-1.25 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -5935070 USD Source
Operating Cash Flow: -4691693 USD Source
Capital Expenditure: 33293 USD Source
Capital Expenditure: 27466 USD Source

Cash and cash equivalents: 748 thousand USD 2022-12-31 Source
Exact value

747714 USD
Long-term debt including current maturities: Not available
Shares outstanding: 1.24 million shares 2022-12-31 Source
Exact value

1242647 shares

Reported share-count change

109.41% · 649 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

593410 shares · 2021-12-31· Source
1242647 shares · 2022-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

215 thousand USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Revenue: 159588 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 38464 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 11432 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 214564 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 209484 USD · 2022-01-01 – 2022-09-30 Source

Net income

-12.3 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Net income: -2159938 USD · 2022-01-01 – 2022-03-31 Source
Net income: -2513669 USD · 2022-04-01 – 2022-06-30 Source
Net income: -4436753 USD · 2022-07-01 – 2022-09-30 Source
Net income: -12343858 USD · 2022-01-01 – 2022-12-31 Source
Net income: -9110360 USD · 2022-01-01 – 2022-09-30 Source

Operating cash flow

-5.94 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Operating cash flow: -1493658 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -3272138 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -1493658 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -4691693 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -3272138 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -5935070 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -4691693 USD · 2022-01-01 – 2022-09-30 Source

Capital expenditure

33.3 thousand USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Capital expenditure: 6508 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 7471 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 6508 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 27466 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 7471 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 33293 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 27466 USD · 2022-01-01 – 2022-09-30 Source

Free cash flow

-5.97 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Operating cash flow: -1493658 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -3272138 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -1493658 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -4691693 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -3272138 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -5935070 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -4691693 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 6508 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 7471 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 6508 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 27466 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 7471 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 33293 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 27466 USD · 2022-01-01 – 2022-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-03-31.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2022-12-31
Operating income: 8 of 11 periods available· newest 2022-12-31
Net income: 8 of 11 periods available· newest 2022-12-31
Operating cash flow: 8 of 11 periods available· newest 2022-12-31
Capital expenditure: 6 of 11 periods available· newest 2022-12-31
Total assets: 8 of 11 periods available· newest 2022-12-31
Total liabilities: 6 of 11 periods available· newest 2022-12-31
Current assets: 8 of 11 periods available· newest 2022-12-31
Current liabilities: 8 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-19.3%

Prior period

USD 265,747

2021-01-01 – 2021-12-31
Current period

USD 214,564

2022-01-01 – 2022-12-31

Exact inputs and evidence

214564 − 265747 = -51183 USD

265747 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
214564 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Year-over-year change in Revenue: -51183 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 214564 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#728792 Filing: 000121390023025650 Input fundies:Revenue: 265747 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#729119 Filing: 000121390023025650
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.24 million

Prior period

−USD 9.1 million

2021-01-01 – 2021-12-31
Current period

−USD 12.34 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-12343858 − -9100686 = -3243172 USD

-9100686 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-12343858 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Year-over-year change in Net income: -3243172 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -12343858 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#791845 Filing: 000121390023025650 Input fundies:NetIncome: -9100686 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#792185 Filing: 000121390023025650
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 68,278

Prior period

−USD 5.87 million

2021-01-01 – 2021-12-31
Current period

−USD 5.94 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-5935070 − -5866792 = -68278 USD

-5866792 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-5935070 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Year-over-year change in Operating cash flow: -68278 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5935070 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#807519 Filing: 000121390023025650 Input fundies:OperatingCashFlow: -5866792 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#807957 Filing: 000121390023025650
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-43.2%

Prior period

USD 58,647

2021-01-01 – 2021-12-31
Current period

USD 33,293

2022-01-01 – 2022-12-31

Exact inputs and evidence

33293 − 58647 = -25354 USD

58647 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
33293 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Year-over-year change in Capital expenditure: -25354 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 33293 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#809404 Filing: 000121390023025650 Input fundies:CapitalExpenditure: 58647 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#809830 Filing: 000121390023025650
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 214,564 100% of revenue
Cost of revenue USD 160,239 75% of revenue
Operating expenses USD 9.66 million 4,503% of revenue
Operating income −USD 9.61 million −4,478% of revenue
Tax, interest and other Derived USD 2.74 million 1,275% of revenue
Net income −USD 12.34 million −5,753% of revenue

Cash

Operating cash flow −USD 5.94 million −2,766% of revenue
Capital expenditure USD 33,293 16% of revenue
Free cash flow Derived −USD 5.97 million −2,782% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Operating loss: operating costs were 2,311% of revenue.
2019 Operating loss: operating costs were 298% of revenue.
2020 Operating loss: operating costs were 3,057% of revenue.
2021 Operating loss: operating costs were 3,357% of revenue.
2022 Operating loss: operating costs were 4,578% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	0	50 Derived	-50	0 Derived	-50	Unavailable	Source 2015-01-01 – 2015-12-31: 0 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -50 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -50 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 0 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	0	90495 Derived	-90495	238 Derived	-90733	Unavailable	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -90495 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -90733 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -34890 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	0	905200 Derived	-905200	53082 Derived	-958282	-875600 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -905200 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -958282 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -873643 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1957 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	58113	1343236 Derived	-1285123	140979 Derived	-1426102	-1113833 Derived	Source 2018-01-01 – 2018-12-31: 58113 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -1285123 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -1426102 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -1112690 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1143 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	489202	1459390 Derived	-970188	33677 Derived	-1003865	-855731 Derived	Source 2019-01-01 – 2019-12-31: 489202 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -970188 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -1003865 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -854726 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1005 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	93664	2863152 Derived	-2769488	33541 Derived	-2803029	-962035 Derived	Source 2020-01-01 – 2020-12-31: 93664 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -2769488 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -2803029 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -931664 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 30371 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	265747	8922224 Derived	-8656477	444209 Derived	-9100686	-5925439 Derived	Source 2021-01-01 – 2021-12-31: 265747 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -8656477 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -9100686 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -5866792 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 58647 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	214564	9822971 Derived	-9608407	2735451 Derived	-12343858	-5968363 Derived	Source 2022-01-01 – 2022-12-31: 214564 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -9608407 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -12343858 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -5935070 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 33293 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 214.6K 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	0	Revenue: 0 Open source
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	58113	Revenue: 58113 Open source
20192019-12-31	Revenue	489202	Revenue: 489202 Open source
20202020-12-31	Revenue	93664	Revenue: 93664 Open source
20212021-12-31	Revenue	265747	Revenue: 265747 Open source
20222022-12-31	Revenue	214564	Revenue: 214564 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-19.3% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 58113 Open source Revenue: 0 Open source
20192019-12-31	Year over year	741.8%	Revenue: 489202 Open source Revenue: 58113 Open source
20202020-12-31	Year over year	-80.9%	Revenue: 93664 Open source Revenue: 489202 Open source
20212021-12-31	Year over year	183.7%	Revenue: 265747 Open source Revenue: 93664 Open source
20222022-12-31	Year over year	-19.3%	Revenue: 214564 Open source Revenue: 265747 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -4,478.1% 2022

Net margin -5,753% 2022

Free cash flow margin -2,781.6% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	Not reported	Operating Income: -50 Open source Revenue: 0 Open source
20162016-12-31	Operating margin	Not reported	Operating Income: -90495 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -905200 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	-2,211.4%	Operating Income: -1285123 Open source Revenue: 58113 Open source
20192019-12-31	Operating margin	-198.3%	Operating Income: -970188 Open source Revenue: 489202 Open source
20202020-12-31	Operating margin	-2,956.8%	Operating Income: -2769488 Open source Revenue: 93664 Open source
20212021-12-31	Operating margin	-3,257.4%	Operating Income: -8656477 Open source Revenue: 265747 Open source
20222022-12-31	Operating margin	-4,478.1%	Operating Income: -9608407 Open source Revenue: 214564 Open source
20152015-12-31	Net margin	Not reported	Net Income: -50 Open source Revenue: 0 Open source
20162016-12-31	Net margin	Not reported	Net Income: -90733 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -958282 Open source Revenue: 0 Open source
20182018-12-31	Net margin	-2,454%	Net Income: -1426102 Open source Revenue: 58113 Open source
20192019-12-31	Net margin	-205.2%	Net Income: -1003865 Open source Revenue: 489202 Open source
20202020-12-31	Net margin	-2,992.6%	Net Income: -2803029 Open source Revenue: 93664 Open source
20212021-12-31	Net margin	-3,424.6%	Net Income: -9100686 Open source Revenue: 265747 Open source
20222022-12-31	Net margin	-5,753%	Net Income: -12343858 Open source Revenue: 214564 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -34890 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -873643 Open source Capital Expenditure: 1957 Open source
20182018-12-31	Free cash flow margin	-1,916.7%	Revenue: 58113 Open source Operating Cash Flow: -1112690 Open source Capital Expenditure: 1143 Open source
20192019-12-31	Free cash flow margin	-174.9%	Revenue: 489202 Open source Operating Cash Flow: -854726 Open source Capital Expenditure: 1005 Open source
20202020-12-31	Free cash flow margin	-1,027.1%	Revenue: 93664 Open source Operating Cash Flow: -931664 Open source Capital Expenditure: 30371 Open source
20212021-12-31	Free cash flow margin	-2,229.7%	Revenue: 265747 Open source Operating Cash Flow: -5866792 Open source Capital Expenditure: 58647 Open source
20222022-12-31	Free cash flow margin	-2,781.6%	Revenue: 214564 Open source Operating Cash Flow: -5935070 Open source Capital Expenditure: 33293 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.9M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
20162016-12-31	Operating cash flow	-34890	Operating Cash Flow: -34890 Open source
20172017-12-31	Operating cash flow	-873643	Operating Cash Flow: -873643 Open source
20182018-12-31	Operating cash flow	-1112690	Operating Cash Flow: -1112690 Open source
20192019-12-31	Operating cash flow	-854726	Operating Cash Flow: -854726 Open source
20202020-12-31	Operating cash flow	-931664	Operating Cash Flow: -931664 Open source
20212021-12-31	Operating cash flow	-5866792	Operating Cash Flow: -5866792 Open source
20222022-12-31	Operating cash flow	-5935070	Operating Cash Flow: -5935070 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -34890 Open source
20172017-12-31	Free cash flow	-875600	Operating Cash Flow: -873643 Open source Capital Expenditure: 1957 Open source
20182018-12-31	Free cash flow	-1113833	Operating Cash Flow: -1112690 Open source Capital Expenditure: 1143 Open source
20192019-12-31	Free cash flow	-855731	Operating Cash Flow: -854726 Open source Capital Expenditure: 1005 Open source
20202020-12-31	Free cash flow	-962035	Operating Cash Flow: -931664 Open source Capital Expenditure: 30371 Open source
20212021-12-31	Free cash flow	-5925439	Operating Cash Flow: -5866792 Open source Capital Expenditure: 58647 Open source
20222022-12-31	Free cash flow	-5968363	Operating Cash Flow: -5935070 Open source Capital Expenditure: 33293 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

63.2% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	Total Assets: 50 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 3580 Open source
20172017-12-31	Liabilities / assets	393.8%	Total Liabilities: 1220693 Open source Total Assets: 310012 Open source
20182018-12-31	Liabilities / assets	130%	Total Liabilities: 234086 Open source Total Assets: 180114 Open source
20192019-12-31	Liabilities / assets	407.7%	Total Liabilities: 1186534 Open source Total Assets: 291002 Open source
20202020-12-31	Liabilities / assets	991.7%	Total Liabilities: 2232719 Open source Total Assets: 225131 Open source
20212021-12-31	Liabilities / assets	105.2%	Total Liabilities: 14070149 Open source Total Assets: 13375216 Open source
20222022-12-31	Liabilities / assets	63.2%	Total Liabilities: 7426403 Open source Total Assets: 11743625 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.18× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	0.5×	Current Assets: 50 Open source Current Liabilities: 100 Open source
20162016-12-31	Current assets / current liabilities	0.04×	Current Assets: 3580 Open source Current Liabilities: 84125 Open source
20172017-12-31	Current assets / current liabilities	0.26×	Current Assets: 308500 Open source Current Liabilities: 1208073 Open source
20182018-12-31	Current assets / current liabilities	0.78×	Current Assets: 178115 Open source Current Liabilities: 226991 Open source
20192019-12-31	Current assets / current liabilities	0.24×	Current Assets: 289328 Open source Current Liabilities: 1186534 Open source
20202020-12-31	Current assets / current liabilities	0.06×	Current Assets: 133389 Open source Current Liabilities: 2121242 Open source
20212021-12-31	Current assets / current liabilities	0.26×	Current Assets: 1131774 Open source Current Liabilities: 4343509 Open source
20222022-12-31	Current assets / current liabilities	0.18×	Current Assets: 1308002 Open source Current Liabilities: 7419025 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 50 Exact value Exact value: -50 USD 2015-01-01 – 2015-12-31: -50 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2015-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -50 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000118518517002310/asg-20161231.xml#20020 Filing: 000118518517002310 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2015-01-01 – 2015-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2015-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000118518517002310/asg-20161231.xml#24481 Filing: 000118518517002310 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 90,733 Exact value Exact value: -90733 USD 2016-01-01 – 2016-12-31: -90733 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2016-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -90733 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -90733 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000118518518001247/asg-20171231.xml#26648 Filing: 000118518518001247 The citation records this snapshot. The page link may show a newer release later.	−USD 34,890 Exact value Exact value: -34890 USD 2016-01-01 – 2016-12-31: -34890 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2016-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -34890 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34890 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000118518518001247/asg-20171231.xml#32227 Filing: 000118518518001247 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 958,282 Exact value Exact value: -958282 USD 2017-01-01 – 2017-12-31: -958282 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2017-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -958282 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -958282 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020002093/brsf-20190930.xml#127751 Filing: 000121390020002093 The citation records this snapshot. The page link may show a newer release later.	−USD 873,643 Exact value Exact value: -873643 USD 2017-01-01 – 2017-12-31: -873643 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2017-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -873643 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -873643 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020002093/brsf-20190930.xml#129526 Filing: 000121390020002093 The citation records this snapshot. The page link may show a newer release later.	USD 1,957 Exact value Exact value: 1957 USD 2017-01-01 – 2017-12-31: 1957 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Brain Scientific Inc. · 2017-12-31 Brain Scientific Inc. (edgar:1662382) Capital Expenditure: 1957 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1957 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020002093/brsf-20190930.xml#223013 Filing: 000121390020002093 The citation records this snapshot. The page link may show a newer release later.	−USD 875,600 Calculation and evidence -873643 − 1957 USD Exact free cash flow: -875600 USD 2017-01-01 – 2017-12-31: -873643 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1957 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Brain Scientific Inc. · 2017-12-31 Brain Scientific Inc. (edgar:1662382) Free cash flow: -875600 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -873643 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020002093/brsf-20190930.xml#129526 Filing: 000121390020002093 Input fundies:CapitalExpenditure: 1957 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020002093/brsf-20190930.xml#223013 Filing: 000121390020002093 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 1.43 million Exact value Exact value: -1426102 USD 2018-01-01 – 2018-12-31: -1426102 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2018-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -1426102 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1426102 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020008234/brsf-20191231.xml#87407 Filing: 000121390020008234 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 million Exact value Exact value: -1112690 USD 2018-01-01 – 2018-12-31: -1112690 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2018-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -1112690 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1112690 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020008234/brsf-20191231.xml#88857 Filing: 000121390020008234 The citation records this snapshot. The page link may show a newer release later.	USD 1,143 Exact value Exact value: 1143 USD 2018-01-01 – 2018-12-31: 1143 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Brain Scientific Inc. · 2018-12-31 Brain Scientific Inc. (edgar:1662382) Capital Expenditure: 1143 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1143 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020008234/brsf-20191231.xml#122515 Filing: 000121390020008234 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 million Calculation and evidence -1112690 − 1143 USD Exact free cash flow: -1113833 USD 2018-01-01 – 2018-12-31: -1112690 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1143 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Brain Scientific Inc. · 2018-12-31 Brain Scientific Inc. (edgar:1662382) Free cash flow: -1113833 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1112690 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020008234/brsf-20191231.xml#88857 Filing: 000121390020008234 Input fundies:CapitalExpenditure: 1143 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390020008234/brsf-20191231.xml#122515 Filing: 000121390020008234 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 1 million Exact value Exact value: -1003865 USD 2019-01-01 – 2019-12-31: -1003865 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2019-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -1003865 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1003865 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390021021685/brsf-20201231.xml#100676 Filing: 000121390021021685 The citation records this snapshot. The page link may show a newer release later.	−USD 854,726 Exact value Exact value: -854726 USD 2019-01-01 – 2019-12-31: -854726 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2019-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -854726 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -854726 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390021021685/brsf-20201231.xml#118174 Filing: 000121390021021685 The citation records this snapshot. The page link may show a newer release later.	USD 1,005 Exact value Exact value: 1005 USD 2019-01-01 – 2019-12-31: 1005 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Brain Scientific Inc. · 2019-12-31 Brain Scientific Inc. (edgar:1662382) Capital Expenditure: 1005 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1005 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390021021685/brsf-20201231.xml#118480 Filing: 000121390021021685 The citation records this snapshot. The page link may show a newer release later.	−USD 855,731 Calculation and evidence -854726 − 1005 USD Exact free cash flow: -855731 USD 2019-01-01 – 2019-12-31: -854726 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1005 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Brain Scientific Inc. · 2019-12-31 Brain Scientific Inc. (edgar:1662382) Free cash flow: -855731 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -854726 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390021021685/brsf-20201231.xml#118174 Filing: 000121390021021685 Input fundies:CapitalExpenditure: 1005 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390021021685/brsf-20201231.xml#118480 Filing: 000121390021021685 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 2.8 million Exact value Exact value: -2803029 USD 2020-01-01 – 2020-12-31: -2803029 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2020-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -2803029 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2803029 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390022046747/ea163852-s1_brainscient.htm#1706676 Filing: 000121390022046747 The citation records this snapshot. The page link may show a newer release later.	−USD 931,664 Exact value Exact value: -931664 USD 2020-01-01 – 2020-12-31: -931664 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2020-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -931664 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -931664 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390022046747/ea163852-s1_brainscient.htm#1719268 Filing: 000121390022046747 The citation records this snapshot. The page link may show a newer release later.	USD 30,371 Exact value Exact value: 30371 USD 2020-01-01 – 2020-12-31: 30371 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Brain Scientific Inc. · 2020-12-31 Brain Scientific Inc. (edgar:1662382) Capital Expenditure: 30371 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30371 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390022046747/ea163852-s1_brainscient.htm#1721186 Filing: 000121390022046747 The citation records this snapshot. The page link may show a newer release later.	−USD 962,035 Calculation and evidence -931664 − 30371 USD Exact free cash flow: -962035 USD 2020-01-01 – 2020-12-31: -931664 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 30371 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Brain Scientific Inc. · 2020-12-31 Brain Scientific Inc. (edgar:1662382) Free cash flow: -962035 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -931664 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390022046747/ea163852-s1_brainscient.htm#1719268 Filing: 000121390022046747 Input fundies:CapitalExpenditure: 30371 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390022046747/ea163852-s1_brainscient.htm#1721186 Filing: 000121390022046747 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 9.1 million Exact value Exact value: -9100686 USD 2021-01-01 – 2021-12-31: -9100686 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2021-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -9100686 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9100686 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#792185 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.	−USD 5.87 million Exact value Exact value: -5866792 USD 2021-01-01 – 2021-12-31: -5866792 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2021-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -5866792 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5866792 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#807957 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.	USD 58,647 Exact value Exact value: 58647 USD 2021-01-01 – 2021-12-31: 58647 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Brain Scientific Inc. · 2021-12-31 Brain Scientific Inc. (edgar:1662382) Capital Expenditure: 58647 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 58647 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#809830 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.	−USD 5.93 million Calculation and evidence -5866792 − 58647 USD Exact free cash flow: -5925439 USD 2021-01-01 – 2021-12-31: -5866792 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 58647 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Brain Scientific Inc. · 2021-12-31 Brain Scientific Inc. (edgar:1662382) Free cash flow: -5925439 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5866792 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#807957 Filing: 000121390023025650 Input fundies:CapitalExpenditure: 58647 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#809830 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 12.34 million Exact value Exact value: -12343858 USD 2022-01-01 – 2022-12-31: -12343858 USD Inspect Net Income Open source Share or cite Citation for Net Income · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Net Income: -12343858 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12343858 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#791845 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.	−USD 5.94 million Exact value Exact value: -5935070 USD 2022-01-01 – 2022-12-31: -5935070 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Operating Cash Flow: -5935070 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5935070 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#807519 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.	USD 33,293 Exact value Exact value: 33293 USD 2022-01-01 – 2022-12-31: 33293 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Capital Expenditure: 33293 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33293 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#809404 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.	−USD 5.97 million Calculation and evidence -5935070 − 33293 USD Exact free cash flow: -5968363 USD 2022-01-01 – 2022-12-31: -5935070 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 33293 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Brain Scientific Inc. · 2022-12-31 Brain Scientific Inc. (edgar:1662382) Free cash flow: -5968363 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:47:44Z Snapshot: c296fead01d2ed78040e2f8db52995d5d52e03835734688885a11fb988f05929 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1662382?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5935070 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#807519 Filing: 000121390023025650 Input fundies:CapitalExpenditure: 33293 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1662382/000121390023025650/f10k2022_brainscientific.htm#809404 Filing: 000121390023025650 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 1,880 latest values · 1,897 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001662382, 1662382, N/A, brsf, edgar:1662382

Also known as ALL SOFT GELS INC, All Soft Gels Inc, BRAIN SCIENTIFIC INC., BRAIN SCIENTIFIC INC., Brain Scientific Inc.

Brain Scientific Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation